Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Vote in favor of your #1 Sort of Convenience for a Family - 2This ‘CSI: Miami’ star spent years solving crimes on TV. Then she became the target of one herself.
- 3Doctors say changes to US vaccine recommendations are confusing parents and could harm kids
- 4Vote In favor of Your Favored Menial helper Administration
- 5‘Democratizing space’ is more than just adding new players – it comes with questions around sustainability and sovereignty
- Should you get an RSV vaccine this fall? What to know and where to get a shot
- Manual for 6 Busssiness Class Flights
- Avoid Slam: Clearing the Street for the Eventual fate of Standard Size Trucks
- Figure out How to Assess the Unwavering quality of SUVs for Seniors
- Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
- Famous Versatile Brands: Your Decision
- Day to day Temporary Positions That Compensate Fairly in the US
- Best bar-b-que Style: Which One Is Your Number one?
- Brexit's Effect on New York's Ascent as a Main Monetary Center
